← Back to Search

Philips FAST SpO2 Performance Across Skin Tones

N/A
Recruiting
Research Sponsored by Masimo Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-3 hours
Awards & highlights

Study Summary

This trial tests how well Philips FAST SpO2 works in measuring oxygen levels in subjects with different skin tones.

Who is the study for?
This trial is for healthy adults aged 18-50, weighing at least 110 lbs, with stable heart rate and blood pressure. Participants must have normal hemoglobin levels, not be pregnant or breastfeeding, and free from certain medical conditions like stroke or heart attack. They should not have a fear of blood draws or any skin issues that could affect the sensor's placement.Check my eligibility
What is being tested?
The Philips FAST SpO2 system paired with Masimo Pulse Oximetry Sensors is being tested to see how well it measures oxygen saturation in the blood across different skin tones compared to a standard reference method.See study design
What are the potential side effects?
Since this study involves non-invasive monitoring with pulse oximetry sensors, side effects are minimal but may include temporary discomfort where the sensor is placed or minor skin irritation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-3 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-3 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Oxygen saturation performance of Philips FAST SpO2 with Masimo pulse oximetry sensors
Secondary outcome measures
Difference in oxygen saturation performance between three population subgroups

Trial Design

1Treatment groups
Experimental Treatment
Group I: Test SubjectExperimental Treatment1 Intervention
All subjects who are enrolled into the test group and participate in data collection have the Philips FAST SpO2 with Masimo Pulse Oximetry Sensors

Find a Location

Who is running the clinical trial?

Masimo CorporationLead Sponsor
111 Previous Clinical Trials
13,053 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are enrolled in this clinical experimentation?

"Affirmative. Data hosted on clinicaltrials.gov confirms that this health study, which was first advertised on November 13th 2023, is currently recruiting. Approximately 24 patients need to be enlisted from 1 medical facility."

Answered by AI

Are patients currently able to enroll in this research study?

"According to the information on clinicaltrials.gov, this study is presently recruiting patients. The original posting date was November 13th 2023 and it was last updated a week later on November 20th of the same year."

Answered by AI

Does this trial enrolment extend to senior citizens?

"This experiment requires that participants are within the age range of 18 to 50. Alternative trials exist for minors and those over 65, as there are 65 studies specifically designed for children and 415 clinicals targeting seniors."

Answered by AI

Is there an opportunity to become involved in this clinical investigation?

"This trial is looking for 24 healthy individuals aged between 18 and 50 to take part."

Answered by AI

Who else is applying?

What site did they apply to?
Masimo Corporation
What portion of applicants met pre-screening criteria?
Did not meet criteria
~16 spots leftby Apr 2025